Clinically, during the early phase of PDAC development, TGF-β1 expression is inversely associated with granzyme B (GzmB), a cytolytic granule that plays a pivotal role in natural killer (NK) cell-mediated cytotoxicity against early-stage cancers [10]. Here, GZMB is linked to cancer.